Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- JAK2V617F mutation
- JAK2V617F allele burden
- essential thrombocythaemia
- bone marrow biopsy
- morphological changes
Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm (MPN) that primarily involves the megakaryocytic lineage.1 The JAK2V617F mutation has been detected in 50–60% of ETs, and homozygous mutation in only 5%.2
JAK2V617F mutation has been associated with a polycythaemia vera (PV)-like phenotype3 and increased risk of thrombosis,4 especially in homozygous patients.5 Increasing mutant allele load was correlated with older age, splenomegaly, microvessel symptoms and higher frequency of arterial thrombosis at diagnosis.2
Little is known on the association between JAK2V617F mutation and histological changes in bone marrow biopsy (BMB) of ET patients.
One hundred and three consecutive patients with newly diagnosed ET, admitted to the Division of Haematology, S. Giovanni Hospital and University of Turin, Italy, from 2006 to 2010 were included in the study. Diagnosis of ET was performed according to WHO criteria.1 A general informed consent was obtained according to the local ethical committee guidelines. There were 56 women and 47 men; the mean age was 59.1 years (range, 25–86). Splenomegaly was detected in 38 patients (36.9%). Venous or arterial thrombosis (confirmed by ultrasound examination or CT scan and D-dimer assessment) were found in 21% and 7% of patients, respectively. …
Funding This work was supported by grants from the Italian Ministero dell'Università e Ricerca Scientifica e Tecnologica (MURST).
Competing interests None.
Ethics approval Ethics approval was provided by Ethics Committee of A.S.O San Giovanni Battista—A.S.O. C.T.O./C.R.F./ Maria Adelaide of Turin.
Provenance and peer review Not commissioned; externally peer reviewed.